Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A dual-function host-guest antioxidant system for synergistic treatment of diquat poisoning.

RSC advances·2026

Same author

EECFS: Efficient Ensemble Causal Feature Selection for High-Dimensional Molecular Data.

Journal of chemical information and modeling·2026

Same author

Structural network dysfunction and aberrant SC-FC coupling correlate with central post-stroke pain of thalamic origin.

The journal of pain·2026

Same author

Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis.

Frontiers in immunology·2026

Same author

Contrasting greenhouse gas fluxes in a city river-lake continuum: CH<sub>4</sub> diffusive emissions offset by N<sub>2</sub>O sequestration.

Environmental research·2026

Same author

AI Versus Human-Delivered Online Cognitive Behavioral Therapy for Anxiety Symptoms in Young Adults: A Randomized Controlled Trial.

Healthcare (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Aug 15, 2025

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

A novel molecular classification method for osteosarcoma based on tumor cell differentiation trajectories.

Hao Zhang^1,2,3, Ting Wang^1,2, Haiyi Gong¹

¹Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Naval Military Medical University, Shanghai, 200003, China.

|January 1, 2023

Summary

This study introduces a new method for classifying osteosarcoma (OS) using single-cell RNA sequencing. This approach identifies distinct patient subgroups with varying prognoses and potential drug sensitivities, paving the way for tailored cancer treatments.

More Related Videos

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Related Experiment Videos

Last Updated: Aug 15, 2025

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Area of Science:

Oncology
Genomics
Biotechnology

Background:

Osteosarcoma (OS) subclassification is crucial for targeted therapy, but traditional methods struggle with its complex cell origins.
Single-cell RNA sequencing (scRNA-seq) offers potential for uncovering cellular heterogeneity in tumors.

Purpose of the Study:

To develop a novel subclassification system for osteosarcoma using scRNA-seq data.
To identify distinct OS subgroups with different clinical outcomes and therapeutic vulnerabilities.

Main Methods:

Analysis of scRNA-seq data from osteosarcoma and cancellous bone samples.
Identification of differentiation trajectories from cancer stem cell (CSC)-like populations.
Validation of the classification model using the TARGET dataset and immunohistochemistry (IHC) staining.

Main Results:

Discovery of three distinct OS subgroups based on differentiation trajectories from CSCs.
Correlation of OS subgroups with differential prognoses and drug sensitivities.
Identification of a novel CSC transcriptional program and EZH2 activation in OS CSCs.

Conclusions:

scRNA-seq provides a powerful tool for osteosarcoma subclassification, revealing distinct patient groups.
This novel classification aids in understanding OS heterogeneity and offers a basis for precision medicine.
Findings highlight the role of CSCs and EZH2 in OS, informing future therapeutic strategies.